These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 16718270

  • 1. Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions.
    Kuźbicki L, Gajo B, Chwirot BW.
    Melanoma Res; 2006 Jun; 16(3):235-43. PubMed ID: 16718270
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression.
    Kuźbicki L, Sarnecka A, Chwirot BW.
    Melanoma Res; 2006 Feb; 16(1):29-36. PubMed ID: 16432453
    [Abstract] [Full Text] [Related]

  • 4. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA, Guitart J, Rao MS, Diaz LK.
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
    Simonetti O, Lucarini G, Brancorsini D, Nita P, Bernardini ML, Biagini G, Offidani A.
    Cancer; 2002 Nov 01; 95(9):1963-70. PubMed ID: 12404291
    [Abstract] [Full Text] [Related]

  • 6. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
    Miracco C, De Nisi MC, Arcuri F, Cosci E, Pacenti L, Toscano M, Lalinga AV, Biagioli M, Rubegni P, Vatti R, Maellaro E, Del Bello B, Massi D, Luzi P, Tosi P.
    Int J Oncol; 2006 Feb 01; 28(2):345-52. PubMed ID: 16391788
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
    Massi D, Naldini A, Ardinghi C, Carraro F, Franchi A, Paglierani M, Tarantini F, Ketabchi S, Cirino G, Hollenberg MD, Geppetti P, Santucci M.
    Hum Pathol; 2005 Jun 01; 36(6):676-85. PubMed ID: 16021575
    [Abstract] [Full Text] [Related]

  • 9. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
    Bauer R, Wild PJ, Meyer S, Bataille F, Pauer A, Klinkhammer-Schalke M, Hofstaedter F, Bosserhoff AK.
    J Clin Pathol; 2006 Jul 01; 59(7):699-705. PubMed ID: 16565225
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
    Gambichler T, Rotterdam S, Radkowski K, Altmeyer P, Kreuter A.
    Am J Clin Pathol; 2009 May 01; 131(5):710-4. PubMed ID: 19369632
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
    Chwirot BW, Kuźbicki Ł.
    Melanoma Res; 2007 Jun 01; 17(3):139-45. PubMed ID: 17505259
    [Abstract] [Full Text] [Related]

  • 14. [Expression of galanin in melanocytic tumors].
    Gilaberte Y, Vera J, Coscojuela C, Roca MJ, Parrado C, González S.
    Actas Dermosifiliogr; 2007 Jun 01; 98(1):24-34. PubMed ID: 17374330
    [Abstract] [Full Text] [Related]

  • 15. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J, Cronin F, Duncan LM.
    Hum Pathol; 2000 Nov 01; 31(11):1346-56. PubMed ID: 11112208
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T, Stolz W, Welsh J, Jung B, Kerbel RS, Kobayashi H, Landthaler M, McClelland M.
    Clin Cancer Res; 1998 Mar 01; 4(3):791-7. PubMed ID: 9533549
    [Abstract] [Full Text] [Related]

  • 19. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS, Shakhtour B, Shyr Y.
    J Am Acad Dermatol; 2008 May 01; 58(5):750-4. PubMed ID: 18249467
    [Abstract] [Full Text] [Related]

  • 20. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
    Bosserhoff AK, Moser M, Hein R, Landthaler M, Buettner R.
    J Pathol; 1999 Mar 01; 187(4):446-54. PubMed ID: 10398105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.